December 12, 2016 / 10:19 AM / 8 months ago

BRIEF-Almirall signs strategic deal with Nuevolution for skin diseases treatment

Dec 12 (Reuters) - Almirall SA :

* Signs strategic deal with Nuevolution for the treatment of inflammatory skin diseases and psoriatic arthritis

* Nuevolution will receive an initial payment of 11.2 million euros ($11.9 million) and may receive additional payments for development and regulatory milestones of up to 172 million euros

* Says agreement with Nuevolution could generate commercial milestones of up to 270 million euros

* Nuevolution would also be entitled to receive royalties on the level of future net sales Source text for Eikon: Further company coverage: ($1 = 0.9442 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below